抗肿瘤中药靶向制剂研究进展  

Progress in Targeting Agents of Antitumor Chinese Medicine

作　　者：商磊[1] 郭伟英[1] 

机构地区：[1]辽宁医学院药学院

出　　处：《医学综述》2009年第16期2435-2437,共3页Medical Recapitulate

摘　　要：中医药治疗癌症等疑难病有较大的优势。与西药相比，在疗效确切的情况下，有较少的不良反应。靶向制剂目前被认为是搭载抗癌药的最适宜剂型，是药剂学研究的热点，也是富有临床应用价值的新剂型。本文对各种抗肿瘤中药靶向制剂的研究进展进行了综述。Chinese medicine has many advantages in treatment of difficult diseases including of cancer. Compared with Western medicine, Chinese medicine has a less of adverse reactions in the case of the exact effect. As a new dosage form with good clinical value, targeted drug delivering system has been regarded as the most appropriate dosage for anti-cancer drngs,and has been the pharmaceutical research hot. This paper reviewed progress in targeting agents of antitumor chinese medicine.

关 键 词：中药 抗肿瘤药 靶向制剂 

分 类 号：R944.9[医药卫生—药剂学]